Context Therapeutics Inc. Common Stock (CNTX) is a publicly traded Healthcare sector company. As of July 11, 2026, CNTX trades at $0.66 with a market cap of $54.62M and a P/E ratio of -1.68. CNTX moved +9.60% today. Year to date, CNTX is -55.59%; over the trailing twelve months it is -2.57%. Its 52-week range spans $0.49 to $3.62. Analyst consensus is strong buy with an average price target of $5.67. Rallies surfaces CNTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for CNTX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $0.66 |
| Market Cap | $54.62M |
| P/E Ratio | -1.68 |
| EPS | $-0.38 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.62 |
| 52-Week Low | $0.49 |
| Volume | 3.80M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-36.12M |
| Gross Margin | 0.00% |
7 analysts cover CNTX: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $5.67.